Palliative Radiotherapy Improved Hoarseness Caused by Supraclavicular Lymph Node Metastasis of Lung Cancer: A Case Report
Case Reports in Oncology · 2026-10-06 · 19 (1) · 1898-1905
DOI: 10.1159/cro/abzag069 ↗Abstract
Abstract Introduction Hoarseness due to malignancy-induced recurrent laryngeal nerve (RLN) palsy can substantially impair patients’ quality of life (QoL). Radiotherapy is used for the palliative treatment of symptoms from various malignant tumors; however, few studies have evaluated its efficacy for hoarseness. Case Presentation An 84-year-old man with right lower lobe lung cancer underwent right S6 segmentectomy followed by chemotherapy, which was discontinued as the result of adverse effects and the patient’s preference. Approximately 1 year later, he developed hoarseness secondary to RLN palsy, owing to the progression of right supraclavicular lymph node metastasis. Palliative radiotherapy (30 Gy in 10 fractions) was administered 3 weeks after the onset of symptoms. The lesion subsequently shrank, and 4 months post-radiotherapy, the hoarseness was resolved. Conclusion The case presented herein suggests that radiotherapy may contribute to symptom improvement in patients with malignancy-induced RLN palsy. Radiotherapy should be considered in similar cases, as it may play a significant role in maintaining and/or improving QoL.
EUVIMED